These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10610568)
21. Effects of statins. Reynolds TM; Wierzbicki AS Lancet; 2000 Sep; 356(9236):1195. PubMed ID: 11030324 [No Abstract] [Full Text] [Related]
22. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs. Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500 [TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
24. [Osteoporosis and bone morphogenetic protein (BMP)]. Higuchi C; Nakase T Nihon Rinsho; 2005 Oct; 63 Suppl 10():439-43. PubMed ID: 16279679 [No Abstract] [Full Text] [Related]
25. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors. Yang SH; Choi JS; Choi DH Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429 [TBL] [Abstract][Full Text] [Related]
26. Effects of simvastatin on bone regeneration in the mandibles of ovariectomized rats and on blood cholesterol levels. Junqueira JC; Mancini MN; Carvalho YR; Anbinder AL; Balducci I; Rocha RF J Oral Sci; 2002 Dec; 44(3-4):117-24. PubMed ID: 12613499 [TBL] [Abstract][Full Text] [Related]
30. A gift from nature: the birth of the statins. Endo A Nat Med; 2008 Oct; 14(10):1050-2. PubMed ID: 18841147 [No Abstract] [Full Text] [Related]
31. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523 [TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo. Bradley JD; Cleverly DG; Burns AM; Helm NB; Schmid MJ; Marx DB; Cullen DM; Reinhardt RA J Periodontal Res; 2007 Jun; 42(3):267-73. PubMed ID: 17451547 [TBL] [Abstract][Full Text] [Related]
33. [Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis]. Sinzinger H Dtsch Med Wochenschr; 1998 Sep; 123(38):1116-22. PubMed ID: 9787294 [No Abstract] [Full Text] [Related]
34. [Simvastatin]. Burgmer U; Mohr K Dtsch Med Wochenschr; 1996 Jun; 121(23):769-70. PubMed ID: 8646995 [No Abstract] [Full Text] [Related]
35. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells. Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871 [TBL] [Abstract][Full Text] [Related]
36. The role of statins in the differentiation and function of bone cells. Chamani S; Liberale L; Mobasheri L; Montecucco F; Al-Rasadi K; Jamialahmadi T; Sahebkar A Eur J Clin Invest; 2021 Jul; 51(7):e13534. PubMed ID: 33656763 [TBL] [Abstract][Full Text] [Related]
37. Statins do more than just lower cholesterol. Vaughan CJ; Murphy MB; Buckley BM Lancet; 1996 Oct; 348(9034):1079-82. PubMed ID: 8874463 [No Abstract] [Full Text] [Related]